Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 1
2009 1
2010 1
2011 3
2012 6
2013 2
2014 5
2015 4
2016 2
2017 3
2018 2
2019 4
2020 6
2021 9
2022 5
2023 2

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.
Woyach JA, Ruppert AS, Heerema NA, Zhao W, Booth AM, Ding W, Bartlett NL, Brander DM, Barr PM, Rogers KA, Parikh SA, Coutre S, Hurria A, Brown JR, Lozanski G, Blachly JS, Ozer HG, Major-Elechi B, Fruth B, Nattam S, Larson RA, Erba H, Litzow M, Owen C, Kuzma C, Abramson JS, Little RF, Smith SE, Stone RM, Mandrekar SJ, Byrd JC. Woyach JA, et al. Among authors: ozer hg. N Engl J Med. 2018 Dec 27;379(26):2517-2528. doi: 10.1056/NEJMoa1812836. Epub 2018 Dec 1. N Engl J Med. 2018. PMID: 30501481 Free PMC article. Clinical Trial.
Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib.
Woyach JA, Furman RR, Liu TM, Ozer HG, Zapatka M, Ruppert AS, Xue L, Li DH, Steggerda SM, Versele M, Dave SS, Zhang J, Yilmaz AS, Jaglowski SM, Blum KA, Lozanski A, Lozanski G, James DF, Barrientos JC, Lichter P, Stilgenbauer S, Buggy JJ, Chang BY, Johnson AJ, Byrd JC. Woyach JA, et al. Among authors: ozer hg. N Engl J Med. 2014 Jun 12;370(24):2286-94. doi: 10.1056/NEJMoa1400029. Epub 2014 May 28. N Engl J Med. 2014. PMID: 24869598 Free PMC article.
Angioplasty induces epigenomic remodeling in injured arteries.
Zhang M, Urabe G, Ozer HG, Xie X, Webb A, Shirasu T, Li J, Han R, Kent KC, Wang B, Guo LW. Zhang M, et al. Among authors: ozer hg. Life Sci Alliance. 2022 Feb 15;5(5):e202101114. doi: 10.26508/lsa.202101114. Print 2022 May. Life Sci Alliance. 2022. PMID: 35169042 Free PMC article.
Clonal hematopoiesis of indeterminate potential in the companion dog.
Sebastian K, Özer HG, Howard C, Chadsey L, Lozanski A, Doong TJ, Orwick S, Lozanski G, Ma W, Kisseberth WC, Byrd JC, Harrington BK. Sebastian K, et al. Among authors: ozer hg. Leukemia. 2022 May;36(5):1401-1403. doi: 10.1038/s41375-022-01520-5. Epub 2022 Feb 10. Leukemia. 2022. PMID: 35145204 No abstract available.
Discovery and characterization of the feline miRNAome.
Laganà A, Dirksen WP, Supsavhad W, Yilmaz AS, Ozer HG, Feller JD, Vala KA, Croce CM, Rosol TJ. Laganà A, et al. Among authors: ozer hg. Sci Rep. 2017 Aug 23;7(1):9263. doi: 10.1038/s41598-017-10164-w. Sci Rep. 2017. PMID: 28835705 Free PMC article.
Nullifying epigenetic writer DOT1L attenuates neointimal hyperplasia.
Huang Y, Urabe G, Zhang M, Li J, Ozer HG, Wang B, Kent KC, Guo LW. Huang Y, et al. Among authors: ozer hg. Atherosclerosis. 2020 Sep;308:22-31. doi: 10.1016/j.atherosclerosis.2020.06.002. Epub 2020 Jul 2. Atherosclerosis. 2020. PMID: 32799103 Free PMC article.
Rare t(X;14)(q28;q32) translocation reveals link between MTCP1 and chronic lymphocytic leukemia.
Walker JS, Hing ZA, Sher S, Cronin J, Williams K, Harrington B, Skinner JN, Cempre CB, Gregory CT, Pan A, Yano M, Beaver LP, Walker BR, Labanowska JM, Heerema NA, Mrózek K, Woyach JA, Ruppert AS, Lehman A, Ozer HG, Coppola V, Yan P, Byrd JC, Blachly JS, Lapalombella R. Walker JS, et al. Among authors: ozer hg. Nat Commun. 2021 Nov 3;12(1):6338. doi: 10.1038/s41467-021-26400-x. Nat Commun. 2021. PMID: 34732719 Free PMC article.
Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemia.
Fobare S, Kohlschmidt J, Ozer HG, Mrózek K, Nicolet D, Mims AS, Garzon R, Blachly JS, Orwick S, Carroll AJ, Stone RM, Wang ES, Kolitz JE, Powell BL, Oakes CC, Eisfeld AK, Hertlein E, Byrd JC. Fobare S, et al. Among authors: ozer hg. Blood Adv. 2022 Mar 8;6(5):1371-1380. doi: 10.1182/bloodadvances.2021006242. Blood Adv. 2022. PMID: 34847232 Free PMC article.
50 results